Last reviewed · How we verify
NCT07187986: SUONO-PT 01
Sound Acupuncture in Painful Chemotherapy-Related Neuropathies
NA trial testing Sound acupuncture in Neuropathic Pain in Cancer in 40 participants. Completed in 16 July 2025.
15 July 2025
Quick facts
| Lead sponsor | Ente Ospedaliero Ospedali Galliera |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 17 March 2022 |
| Primary completion | 15 July 2025 |
| Estimated completion | 16 July 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Sound acupuncture
Conditions studied
- Neuropathic Pain in Cancer — all drugs for Neuropathic Pain in Cancer →
Sponsor
Ente Ospedaliero Ospedali Galliera — full company profile →
Who can join
Adults 30 to 80, any sex, with Neuropathic Pain in Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this clinical trial is to evaluate the efficacy of sound acupuncture in combination with traditional medical therapy in the treatment of chemotherapy-induced peripheral neuropathies. Sound acupuncture is a non-invasive technique that involves stimulating energy points, used in acupuncture, with the help of specific tuning forks and the frequencies they emit. The energy points are those used in Chinese medicine and, more specifically, in acupuncture. The aim is to restore the recipient's complex bioenergetic system to an optimal state of well-being and balance Participants: 20 patients will receive only the best medical therapy; 20 patients will receive BMT and sound acupuncture treatment
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07187986
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ente Ospedaliero Ospedali Galliera trials
Trials by the same sponsor.
- NCT07486336 — Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surger · NA · not yet recruiting
- NCT07483840 — Analgesic Techniques for Robotic Prostatectomy Procedures · NA · not yet recruiting
- NCT06994208 — Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age. · recruiting
- NCT05601700 — Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) · Phase 3 · recruiting
- NCT04932863 — BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07187986 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ente Ospedaliero Ospedali Galliera
- Last refreshed: 23 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07187986.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing